Survey on the Effectiveness of the PLAB Examination in Continuing Clinical Education in British Doctors.
October 18, 2022 updated by: Samer Makki Mohamed Al-Hakkak, Jabir Ibn Hayyan Medical University
Survey the Effectiveness of PLAB Examination in Further Clinical Training in the United Kingdom
Online survey for all international medical graduate doctors who decided to get a job in the UK; they must do GMC registration.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
West Suffolk
-
Westbury On Severn, West Suffolk, United Kingdom
- West Suffolk Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
cross-sectional
Description
Inclusion Criteria:
- Post-PLAB exam and GMC registration international medical graduate
- Candidates who practise in NHS as FY1 and FY2
Exclusion Criteria:
- Pass PLAB one exam
- Pass PLAB two exam
- Candidates pass PLAB one and two but still not working in NHS
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
cross section online google form questioner
Time Frame: 1 month
|
cross section online google form questioner
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 3, 2022
Primary Completion (Actual)
June 4, 2022
Study Completion (Actual)
June 30, 2022
Study Registration Dates
First Submitted
May 2, 2022
First Submitted That Met QC Criteria
May 2, 2022
First Posted (Actual)
May 5, 2022
Study Record Updates
Last Update Posted (Actual)
October 20, 2022
Last Update Submitted That Met QC Criteria
October 18, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- PLAB
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.